Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Abou-Alfa
    Abou-Alfa
  2. Lowe
    Lowe
  3. Capanu
    Capanu
  4. Chiosis
    Chiosis
  5. Chou
    Chou
  6. Erinjeri
    Erinjeri
  7. Harding
    Harding
  8. Ho
    Ho
  9. Kalin
    Kalin
  10. Katz
    Katz

Groups

  1. Department of Medicine (8)
  2. Gastrointestinal Oncology Service (7)
  3. Solid Tumor Oncology Division (7)
  4. Center for Pancreatic Cancer Research (4)
  5. Center for Hematologic Malignancies (3)
  6. GSK Faculty (3)
  7. Sloan Kettering Institute Faculty (3)
  8. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (2)
  9. Cancer Biology and Genetics Program Faculty (2)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (2)
Search Within
  1. "Journal of Hepatology"
Formats
  1. Journal Article (11)
  2. Meeting Abstract (2)
  3. Correspondence (1)
  4. Editorial (1)
  5. Review (1)
Groups
  1. Department of Medicine (8)
  2. Gastrointestinal Oncology Service (7)
  3. Solid Tumor Oncology Division (7)
  4. Center for Pancreatic Cancer Research (4)
  5. Center for Hematologic Malignancies (3)
  6. GSK Faculty (3)

More Groups

People
  1. Ghassan Abou-Alfa (7)
  2. Scott Lowe (2)
  3. Alice Wei (1)
  4. Bolorsukh Gansukh (1)
  5. Changyu Zhu (1)
  6. Danny Khalil (1)

More People

Years
  1. 2025 (2)
  2. 2024 (2)
  3. 2023 (1)
  4. 2021 (3)
  5. 2020 (1)
  6. 2016 (1)

More Years

Publications
  1. Journal of Hepatology (16)

Results (16)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Reply to: “STRIDE's efficacy and safety in Asian hepatocellular carcinoma”
    Correspondence

    Lau, G.; Abou-Alfa, G. K.; Chan, S. L.
    Journal of Hepatology (2025)

    Fulltext@MSK | Save
  • Outcomes in the Asian subgroup of the phase III randomised HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
    Journal Article

    Lau, G.; Abou-Alfa, G. K.; Cheng, A. L.; Sukeepaisarnjaroen, W.; Van Dao, T.; Kang, Y. K.; Thungappa, S. C.; Kudo, M.; Sangro, B.; Kelley, R. K.; more...
    Journal of Hepatology (2025)

    Fulltext@MSK | Save
  • mRECIST outcomes in EMERALD-1: A phase 3, randomized, placebo-controlled study of transarterial chemoembolization plus durvalumab with/without bevacizumab in participants with embolization-eligible hepatocellular carcinoma
    Meeting Abstract

    Sangro, B.; Kudo, M.; Erinjeri, J.; Qin, S.; Ren, Z.; Chan, S.; Arai, Y.; Heo, J.; Mai, A.; Escobar, J.; more...
    Journal of Hepatology (2024)

    Fulltext@MSK | Save
  • Phenotypes and ontogeny of senescent hepatic stellate cells in metabolic dysfunction-associated steatohepatitis
    Journal Article

    Yashaswini, C. N.; Qin, T.; Bhattacharya, D.; Amor, C.; Lowe, S.; Lujambio, A.; Wang, S.; Friedman, S. L.
    Journal of Hepatology (2024)

    Fulltext@MSK | Save
  • Rational development of combination therapies for biliary tract cancers
    Review

    Harding, J. J.; Khalil, D. N.; Fabris, L.; Abou-Alfa, G. K.
    Journal of Hepatology (2023)

    Fulltext@MSK | Save
  • Decision making in systemic therapy of hepatocellular carcinoma: Should we pay attention to disease aetiology?
    Editorial

    Galle, P. R.; Abou-Alfa, G. K.
    Journal of Hepatology (2021)

    Fulltext@MSK | Save
  • Preoperative artemin as predictive biomarker for survival in curatively resected hepatocellular carcinoma
    Meeting Abstract

    Zeuge, U.; Zhan, L.; Bucur, R.; Sauerzopf, K.; Aggarwal, R.; Feng, S.; Sim, H. W.; Cheng, D.; Zhang, W. J.; Moulton, C. A.; more...
    Journal of Hepatology (2021)

    Fulltext@MSK | Save
  • Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features
    Journal Article

    Zhu, C.; Ho, Y. J.; Salomao, M. A.; Dapito, D. H.; Bartolome, A.; Schwabe, R. F.; Lee, J. S.; Lowe, S. W.; Pajvani, U. B.
    Journal of Hepatology (2021)

    Fulltext@MSK | Save
  • Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma
    Journal Article

    Sangro, B.; Melero, I.; Wadhawan, S.; Finn, R. S.; Abou-Alfa, G. K.; Cheng, A. L.; Yau, T.; Furuse, J.; Park, J. W.; Boyd, Z.; more...
    Journal of Hepatology (2020)

    Fulltext@MSK | Save
  • Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma
    Journal Article

    Abou-Alfa, G. K.; Puig, O.; Daniele, B.; Kudo, M.; Merle, P.; Park, J. W.; Ross, P.; Peron, J. M.; Ebert, O.; Chan, S.; more...
    Journal of Hepatology (2016)

    Fulltext@MSK | Save